Skip to main content
. 2023 Apr 3;10:1119699. doi: 10.3389/fcvm.2023.1119699

Table 1.

Clinical data of the study population.

Medical information mart for intensive care IV v2.2 database (training set) eICU Collaborative research database (test set) P value
Total, n 11,156 9,837
Age [mean (SD)] 72.97 (13.62) 70.66 (13.64) <0.001
Male, n (%) 6,238 (55.9) 5,210 (53.0) <0.001
BMI [mean (SD)] 28.92 (6.62) 29.65 (7.27) <0.001
Diabetes, n (%) 4,493 (40.3) 4,016 (40.8) 0.425
Hypertension, n (%) 8,610 (77.2) 6,533 (66.4) <0.001
Severe_liver_disease, n (%) 320 (2.9) 129 (1.3) <0.001
COPD, n (%) 2,274 (20.4) 2,009 (20.4) 0.958
Myocardial_infarct, n (%) 3,667 (32.9) 1,700 (17.3) <0.001
SOFA [mean (SD)] 5.83 (3.62) 5.51 (3.06) <0.001
APS III [mean (SD)] 51.90 (22.52) 47.44 (22.70) <0.001
Heart rate [mean (SD)] 88.24 (20.31) 91.26 (22.86) <0.001
Respiratory rate [mean (SD)] 19.84 (6.19) 22.03 (6.60) <0.001
SpO2 [mean (SD)] 96.58 (4.29) 95.17 (6.65) <0.001
MBP [mean (SD)] 80.47 (18.78) 85.59 (21.91) <0.001
WBC [mean (SD)] 12.37 (8.67) 11.52 (6.46) <0.001
Hematocrit [mean (SD)] 33.00 (7.14) 35.74 (7.26) <0.001
Hemoglobin [mean (SD)] 10.71 (2.38) 11.57 (2.44) <0.001
Platelets [mean (SD)] 215.44 (106.62) 226.82 (105.98) <0.001
RBC [mean (SD)] 3.62 (0.82) 3.96 (0.83) <0.001
MCH [mean (SD)] 29.77 (2.77) 29.34 (2.92) <0.001
MCV [mean (SD)] 91.77 (7.34) 90.69 (7.75) <0.001
MCHC [mean (SD)] 32.46 (1.71) 32.34 (1.57) <0.001
RDW [mean (SD)] 15.42 (2.32) 16.06 (2.49) <0.001
Basophils [mean (SD)] 0.03 (0.04) 0.07 (0.08) <0.001
Eosinophils [mean (SD)] 0.11 (0.24) 0.19 (0.30) <0.001
Lymphocytes [mean (SD)] 1.57 (4.45) 1.52 (2.49) 0.323
Monocytes [mean (SD)] 0.65 (0.69) 0.83 (0.64) <0.001
Neutrophils [mean (SD)] 10.11 (6.21) 8.81 (5.32) <0.001
Albumin [mean (SD)] 3.27 (0.61) 3.18 (0.61) <0.001
ALT [mean (SD)] 83.68 (333.33) 71.36 (327.86) 0.007
AST [mean (SD)] 129.44 (596.34) 91.44 (444.39) <0.001
ALP [mean (SD)] 109.72 (104.02) 110.85 (86.86) 0.399
Total bilirubin [mean (SD)] 1.06 (1.92) 0.93 (1.09) <0.001
BUN [mean (SD)] 33.95 (24.96) 35.06 (23.96) 0.001
Creatinine [mean (SD)] 1.74 (1.68) 1.96 (1.93) <0.001
Glucose [mean (SD)] 154.98 (89.08) 163.11 (93.86) <0.001
Sodium [mean (SD)] 137.96 (5.41) 137.05 (5.47) <0.001
Calcium [mean (SD)] 8.50 (1.08) 8.75 (0.79) <0.001
Chloride [mean (SD)] 102.13 (6.97) 100.65 (6.64) <0.001
Potassium [mean (SD)] 4.41 (0.86) 4.34 (0.81) <0.001
Aniongap [mean (SD)] 15.74 (4.72) 11.75 (5.00) <0.001
Bicarbonate [mean (SD)] 23.57 (5.22) 25.82 (5.85) <0.001
INR [mean (SD)] 1.66 (1.26) 1.68 (1.17) 0.185
PT [mean (SD)] 18.02 (12.72) 18.79 (11.96) <0.001
PTT [mean (SD)] 40.47 (26.22) 36.92 (18.51) <0.001
CRRT [mean (SD)] 0.06 (0.23) 0.07 (0.25) 0.001
Dopamine, n (%) 507 (4.5) 294 (3.0) <0.001
Norepinephrine, n (%) 2,436 (21.8) 1,027 (10.4) <0.001
Dobutamine, n (%) 317 (2.8) 327 (3.3) 0.047
Phenylephrine, n (%) 2,102 (18.8) 252 (2.6) <0.001
Epinephrine, n (%) 956 (8.6) 111 (1.1) <0.001
Vasopressin, n (%) 622 (5.6) 184 (1.9) <0.001
Milrinone, n (%) 382 (3.4) 211 (2.1) <0.001
Blocker, n (%) 5,953 (53.4) 1,788 (18.2) <0.001
ACEI/ARB, n (%) 515 (4.6) 453 (4.6) 0.007
Furosemide, n (%) 5,517 (49.5) 2,507 (25.5) <0.001
Ventilation, n (%) 4,379 (39.3) 4,567 (46.4) <0.001
In-hospital mortality, n (%) 1,484 (13.3) 1,319 (13.4) 0.837

BMI, body mass index; SOFA, sequential organ failure assessment; APS III, acute physiology score III scores; COPD, chronic obstructive pulmonary disease; AECI/ARB, angiotensin converting enzyme I/Angiotensin II receptor blocker; CRRT, continuous renal replacement therapy; WBC, white blood cell count; RBC, red blood cells count; MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin content; MHC, mean hemoglobin concentration; RDW, red blood cell distribution width; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; BUN, urea nitrogen; INR, international normalized ratio; PTT, thromboplastin time; PT, prothrombin time.